Abstract
In an effort to enhance the linear range of anti-CCP we developed a new immunoassay based on time-resolved fluoroimmunoassay. The precision, sensitivity, specificity, and stability of the assay were evaluated ELISA set as control. The anti-CCP IgG TRFIA kit we established had a wider detectable range than commercial ELISA ones. With regard to intra- and inter-assay precision, the TRFIA kit was better than threee commercial ELISA ones. The mean recovery rate was 101.0%. The TRFIA we developed for anti-CCP IgG detection yielded a more sensitive and reliable method for RA diagnosis and large-scale screening programs as well.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Arthritis, Rheumatoid / blood
-
Arthritis, Rheumatoid / diagnosis*
-
Arthritis, Rheumatoid / immunology
-
Autoantibodies / blood*
-
Calibration
-
Enzyme-Linked Immunosorbent Assay
-
Europium / chemistry
-
Fluoroimmunoassay / methods*
-
Fluoroimmunoassay / standards
-
Humans
-
Immunoglobulin G / biosynthesis
-
Immunoglobulin G / chemistry
-
Immunoglobulin G / isolation & purification
-
Mice
-
Peptides, Cyclic / blood
-
Peptides, Cyclic / immunology*
-
Reagent Kits, Diagnostic
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Staining and Labeling / methods
Substances
-
Autoantibodies
-
Immunoglobulin G
-
Peptides, Cyclic
-
Reagent Kits, Diagnostic
-
cyclic citrullinated peptide
-
Europium